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CmeR Functions as a Pleiotropic Regulator and Is Required for Optimal
Colonization of Campylobacter jejuni In Vivo
Abstract
CmeR functions as a transcriptional repressor modulating the expression of the multidrug efflux pump
CmeABC in Campylobacter jejuni. To determine if CmeR also regulates other genes in C. jejuni, we compared
the transcriptome of thecmeR mutant with that of the wild-type strain using a DNA microarray. This
comparison identified 28 genes that showed a ≥2-fold change in expression in thecmeR mutant. Independent
real-time quantitative reverse transcription-PCR experiments confirmed 27 of the 28 differentially expressed
genes. The CmeR-regulated genes encode membrane transporters, proteins involved in C4-dicarboxylate
transport and utilization, enzymes for biosynthesis of capsular polysaccharide, and hypothetical proteins with
unknown functions. Among the genes whose expression was upregulated in the cmeR mutant, Cj0561c
(encoding a putative periplasmic protein) showed the greatest increase in expression. Subsequent experiments
demonstrated that this gene is strongly repressed by CmeR. The presence of the known CmeR-binding site, an
inverted repeat of TGTAAT, in the promoter region of Cj0561c suggests that CmeR directly inhibits the
transcription of Cj0561c. Similar to expression of cmeABC, transcription of Cj0561c is strongly induced by
bile compounds, which are normally present in the intestinal tracts of animals. Inactivation of Cj0561c did not
affect the susceptibility of C. jejuni to antimicrobial compounds in vitro but reduced the fitness of C. jejuniin
chickens. Loss-of-function mutation of cmeR severely reduced the ability of C. jejuni to colonize chickens.
Together, these findings indicate that CmeR governs the expression of multiple genes with diverse functions
and is required forCampylobacter adaptation in the chicken host.
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CmeR functions as a transcriptional repressor modulating the expression of the multidrug efflux pump
CmeABC in Campylobacter jejuni. To determine if CmeR also regulates other genes in C. jejuni, we compared
the transcriptome of the cmeR mutant with that of the wild-type strain using a DNA microarray. This
comparison identified 28 genes that showed a >2-fold change in expression in the cmeR mutant. Independent
real-time quantitative reverse transcription-PCR experiments confirmed 27 of the 28 differentially expressed
genes. The CmeR-regulated genes encode membrane transporters, proteins involved in C4-dicarboxylate
transport and utilization, enzymes for biosynthesis of capsular polysaccharide, and hypothetical proteins with
unknown functions. Among the genes whose expression was upregulated in the cmeR mutant, Cj0561c (encod-
ing a putative periplasmic protein) showed the greatest increase in expression. Subsequent experiments
demonstrated that this gene is strongly repressed by CmeR. The presence of the known CmeR-binding site, an
inverted repeat of TGTAAT, in the promoter region of Cj0561c suggests that CmeR directly inhibits the
transcription of Cj0561c. Similar to expression of cmeABC, transcription of Cj0561c is strongly induced by bile
compounds, which are normally present in the intestinal tracts of animals. Inactivation of Cj0561c did not
affect the susceptibility of C. jejuni to antimicrobial compounds in vitro but reduced the fitness of C. jejuni in
chickens. Loss-of-function mutation of cmeR severely reduced the ability of C. jejuni to colonize chickens.
Together, these findings indicate that CmeR governs the expression of multiple genes with diverse functions
and is required for Campylobacter adaptation in the chicken host.
Campylobacter jejuni is a gram-negative enteric organism
causing gastroenteritis in humans (38). As a major food-borne
pathogen, C. jejuni is well adapted in its mammalian and avian
hosts, as well as in food animal production environments. So
that it can survive in different conditions, C. jejuni has evolved
multiple strategies for adaptation, including high rates of ge-
netic variation (mediated by mutation and horizontal gene
transfer) and differential gene expression (6, 11, 30). Indeed,
previous analyses of the genomic sequences of C. jejuni re-
vealed the presence of multiple genes encoding regulatory
functions (9, 14, 32, 35). The majority of the transcriptional
regulators have not been functionally characterized, but the
two-component regulatory (TCR) systems in C. jejuni have
recently received attention. In C. jejuni NCTC 11168 and
RM1221, each system has nine response regulators and six
histidine sensor kinases (9, 32). Several of the regulators or
TCR systems, including DccRS (28), PhosSR (49), FlgSR (50),
CbrR (36), RacRS (4), and CheY (53), have been studied, and
all were found to be required for Campylobacter colonization in
vivo. The RacRS system is responsive to temperature and
controls the expression of multiple proteins in C. jejuni, while
the PhosSR system senses phosphate conditions and modu-
lates the expression of 12 genes that are involved in phosphate
transport and utilization (4, 49). DccRS controls the expression
of several genes encoding probable membrane-associated pro-
teins and is required for Campylobacter colonization of mice
and chickens, but the signals to which it responds and the
functions of the DccR-regulated genes have not been defined
(28). CbrR modulates the Campylobacter response to bile, but
its cognate sensor kinase and the target genes controlled by it
are unknown (36). The FlgSR system controls the flagellar
regulon and affects the motility of Campylobacter (50). It was
also found that FlaR undergoes phase variation due to the
presence of homopolymeric tracts of adenine and thymine in
the coding gene (13). These examples illustrate that C. jejuni
utilizes multiple TCR systems for adaptation to different en-
vironments.
In addition to the TCR systems, several non-TCR system
regulators, including Fur, SpoT, HspR, and CmeR, have also
been characterized in Campylobacter. Fur functions as a tran-
scriptional repressor and controls iron homeostasis in C. jejuni
(31, 45). Mutation of Fur affected the expression of 53 genes
and significantly reduced the colonization of chickens by
Campylobacter (31). HspR is a negative regulator for the heat
shock response system in C. jejuni, and inactivation of HspR
led to increased expression of several genes involved in the
heat shock response and decreased expression of 17 genes (1).
The HspR mutant showed decreased motility, increased sen-
sitivity to temperature, and reduced adherence to and invasion
of cultured epithelial cells (1). SpoT functions as a regulator
for the stringent response in C. jejuni and is important for the
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survival of Campylobacter under various stress conditions (11).
Deletion of spoT resulted in differential expression of multiple
genes and reduced Campylobacter adherence, invasion, and
intracellular survival in cell cultures (11). In a previous study by
workers in our laboratory (21), a transcriptional regulator des-
ignated CmeR was characterized. CmeR belongs to the TetR
family of transcriptional regulators and functions as a repres-
sor of CmeABC, a resistance-nodulation-division-type efflux
pump (23). The CmeABC pump is composed of three mem-
brane components (CmeA, CmeB, and CmeC) and contributes
to Campylobacter resistance to various antimicrobial agents
and bile compounds present in the intestinal environment (23,
24). Inactivation of CmeABC abolished the ability of C. jejuni
to colonize chickens (24), indicating that bile resistance is an
important physiological function of CmeABC and that this
efflux pump plays an important role in facilitating Campy-
lobacter adaptation to the intestinal tract.
CmeR is encoded by a gene located immediately upstream
of the cmeABC operon and has two distinct domains, an N-
terminal helix-turn-helix (HTH) DNA-binding motif and a po-
tential ligand-binding domain in the C-terminal region (21).
An in vitro electrophoretic mobility shift assay showed that
CmeR binds specifically to the inverted repeat (TGTAAT) in
the promoter region of cmeABC and represses the transcrip-
tion of this efflux operon. Deletion of CmeR or mutation in the
CmeR-binding site impedes the repression and results in over-
expression of CmeABC (21). Importantly, the expression of
cmeABC is strongly induced by bile salts in culture media (22).
Since bile compounds are normally present in animal intestinal
tracts, it is likely that CmeABC is upregulated during in vivo
infection. Indeed, the DNA microarray work conducted by
Stintzi et al. showed that cmeABC was significantly upregu-
lated in rabbit ileal loops (40). Real-time quantitative reverse
transcription-PCR (qRT-PCR) conducted in our laboratory
also showed that there was a 14-fold increase in the expression
of cmeABC in the chicken cecum compared with an in vitro
culture (Y. W. Barton and Q. Zhang, unpublished data). Bile
salts inhibit the binding of CmeR to the promoter DNA of
cmeABC and thus release the inhibition of cmeABC by CmeR
(22), resulting in overexpression of cmeABC. Recent protein
crystallization studies confirmed the two-domain structure of
CmeR and showed that CmeR functions as a homodimer (12).
A striking feature of CmeR revealed by crystallization is the
presence of a large ligand-binding pocket, which has the ca-
pacity and flexibility to accommodate diverse ligands, including
bile salts. This finding suggests that CmeR may interact with
multiple ligands in modulating gene expression in C. jejuni.
Despite the recent advances in our understanding of the
structure and function of CmeR and its transcriptional regu-
lation of cmeABC, it is still unclear if CmeR regulates the
expression of other genes in C. jejuni. It is also not known if
CmeR is important for Campylobacter colonization in vivo. In
this study, we compared the transcriptomes of C. jejuni NCTC
11168 and an isogenic CmeR mutant of this strain using a
DNA microarray along with other molecular methods and
identified multiple genes regulated by CmeR. We also charac-
terized a gene (Cj0561c) that is highly repressed by CmeR and
determined the role of CmeR in Campylobacter colonization in
the chicken model system. Our new findings indicate that
CmeR is a pleiotropic regulator modulating the expression of
multiple genes with diverse functions in Campylobacter and is
required for optimal colonization of chickens.
MATERIALS AND METHODS
Bacterial strains, plasmids, and culture conditions. The various Campy-
lobacter strains, mutants, and plasmids used in this study and their sources are
listed in Table 1. The isolates were routinely grown in Mueller-Hinton (MH)
broth (Difco) or on MH agar plates at 42°C under microaerobic conditions.
Escherichia coli was grown in Luria-Bertani (LB) broth with shaking (250 rpm)
or on LB agar plates at 37°C overnight. When necessary, culture media were
supplemented with ampicillin (100 g/ml), kanamycin (30 g/ml), or chloram-
phenicol (20 g/ml).
Bacterial RNA isolation. C. jejuni NCTC 11168 and the isogenic cmeR mutant
11168cmeR (21) were grown in MH broth for 17 h to the mid-log phase (optical
density at 600 nm, 0.13) and were immediately treated with 2 volumes of
RNAprotect bacterial reagent (Qiagen, Valencia, CA) to stabilize the total
bacterial RNA. After incubation for 5 min at room temperature, the culture was
centrifuged at 10,000 g for 5 min. Bacterial RNA was isolated using an RNeasy
mini kit (Qiagen) according to the manufacturer’s instructions. Isolated RNA
was treated with an on-column DNase digestion kit (Qiagen), which was followed
TABLE 1. Key bacterial plasmids and strains used in this study
Plasmid or strain Description Reference or source
Plasmids
pRY107 E. coli-Campylobacter shuttle vector 52
pRYC7 pRY107 containing the Cj0369c-cmeR operon with the intergenic sequence
upstream of Cj0369c
This study
pRYC1 pRY107 containing the Cj0369c-cmeR operon without the intergenic
sequence upstream of Cj0369c
This study
pMW10 E. coli-Campylobacter shuttle vector carrying a promoterless lacZ gene 48
pMW561 pMW10 derivative with the promoter of Cj0561c inserted upstream of lacZ This study
C. jejuni strains
NCTC 11168 32
11168cmeR NCTC 11168 derivative; cmeR::cat 21
11168cmeR 11168cmeR complemented with pRYC7 This study
11168cmeRC1 11168cmeR carrying pRYC1 This study
11168W7 Highly motile variant of NCTC 11168 (ATCC 700819) ATCCa
11168W7cmeR 11168W7 derivative; cmeR::cat This study
11168W7cmeR 11168W7cmeR complemented with pRYC7 This study
11168W7561 11168W7 derivative; Cj0561c::cat This study
a ATCC, American Type Culture Collection.
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by removal of the DNase using an RNeasy mini kit (Qiagen). The absence of
DNA contamination in the RNA samples was confirmed by reverse transcrip-
tion-PCR (RT-PCR). The concentration of total RNA was determined by mea-
suring the absorbance at 260 nm with a spectrophotometer, and the integrity and
size distribution of the purified RNA were determined by denaturing agarose gel
electrophoresis and ethidium bromide staining. The purified RNA was kept at
80°C until it was used. RNA samples extracted from three independent exper-
iments were used for the microarray hybridization experiments.
cDNA synthesis and labeling. cDNA synthesis and fluorescence labeling were
performed using the SuperScript indirect cDNA labeling system (Invitrogen,
Carlsbad, CA) according to the manufacturer’s instructions. Briefly, 12 g of
total RNA was reverse transcribed using SuperScript III reverse transcriptase
and random hexamers in the presence of an aminoallyl-modified nucleotide and
an aminohexyl-modified nucleotide together with other deoxynucleoside triphos-
phates. The RNA was then hydrolyzed by incubating the reaction mixture with
sodium hydroxide at 70°C for 10 min. The sodium hydroxide was neutralized by
addition of hydrochloric acid. After purification using S.N.A.P. columns (Invitro-
gen) to remove unincorporated nucleotides, the amino-modified cDNAs were
labeled by coupling with a monoreactive, N-hydroxysuccinimide-ester fluorescent
dye, Cy3 or Cy5 (Amersham Biosciences, Piscataway, NJ). A final purification
step using S.N.A.P. columns (Invitrogen) removed unreacted dyes, and the
fluorescently labeled cDNA was used to hybridize microarray slides.
Microarray hybridization. C. jejuni NCTC 11168 microarray slides were pur-
chased from MWG Biotech, Inc. (now Ocimum Biosolutions). The array con-
tained 1,632 oligonucleotide (50-mer) probes covering the entire transcriptome
of NCTC 11168. To compare the gene expression of 11168cmeR with that of
NCTC 11168, equal volumes of Cy3- or Cy5-labeled cDNAs from the wild type
and the cmeR mutant strain were combined and dried with a SpeedVac and then
resuspended in 120 l of hybridization buffer (MWG). The probes were dena-
tured at 95°C for 3 min, briefly cooled on ice, and then hybridized to the
microarray slides using microarray gene frames (MWG). A second microarray
slide was hybridized with the dyes reversed to the two samples to ensure dye
balance in the experimental design. The slides were placed in a wet hybridization
chamber and incubated on a shaker for 20 h at 42°C. After hybridization, the
slides were washed with 2 SSC–0.1% sodium dodecyl sulfate (SDS) for 5 min,
with 1 SSC for 5 min, and with 0.1 SSC for 5 min (1 SSC is 0.15 M NaCl
plus 0.015 M sodium citrate). The washing buffers were prewarmed at 30°C, and
all of the washing steps were performed at room temperature. Finally, the slides
were dried by centrifugation at 500  g for 2 min. The hybridization experiment
was repeated three times by using total RNA isolated in three independent
experiments. Thus, six technical replicates from three biologically independent
experiments were used for data analysis.
Data collection and analysis. Hybridized slides were scanned at a wavelength
of 650 nm for Cy5 and at a wavelength of 550 nm for Cy3 using a General
Scanning ScanArray 5000 (PerkinElmer, Boston, MA) at 10-m resolution. The
fluorescence intensities were collected with the ImaGene software (BioDiscov-
ery, El Segundo, CA). Genes with fluorescence signals within less than 2 standard
deviations of the background were considered insignificant. Background subtrac-
tion, Lowess normalization, scale normalization, and median centering were
performed using the R statistical package (version 2.0.1; The R Foundation for
Statistical Computing). Briefly, the spot-specific median background for each
probe was subtracted from the spot-specific signal mean intensity to obtain a
background-corrected signal intensity for each probe. The natural logarithm of
the signal mean with the background subtracted was normalized using a locally
weighted polynomial regression (Lowess) procedure to control for intensity-
dependent dye bias (8, 51). The resulting values were then median centered by
addition of an additive constant so that the medians of all array-dye combina-
tions equaled zero. Finally, scale normalization was used to normalize the scales
of all channels to a constant value by multiplying each value by C/MADj, where
MADj is the median of the absolute deviations from the median for a given
channel and C is the geometric mean of the collective MADj (51).
The normalized data were subjected to a mixed-linear model analysis using the
SAS statistical package. This analysis was performed on a gene level with fixed
effects of treatment (cmeR mutant versus the wild type) and dye (Cy3 versus Cy5)
and random effects of replications, samples, and slides. As part of this analysis a
t test for differential expression across treatments was performed for each probe,
and the associated P values were converted to Q values to correct for multiple
testing using a previously described method (42). The Q values could be used to
estimate the false discovery rate (FDR) associated with a set of genes declared
to be differentially expressed. For example, the FDR for a list of genes with Q
values less than or equal to 0.1 is estimated to be 10%. The differential data were
obtained by using the inverse natural log of the mean treatment difference. For
this study, we chose a P value of 0.05 and a change equal to or greater than
2.0-fold as the cutoff for significant differential expression in comparisons of the
cmeR mutant and wild-type strain NCTC 11168.
PCR, RT-PCR, and real-time qRT-PCR. Key PCR primers used in this study
are listed in Table 2. PCR was performed in a 50-l mixture containing each
deoxynucleoside triphosphate at a concentration of 200 nM, each primer at a
concentration of 200 nM, 2.0 mM MgCl2, 100 ng of Campylobacter genomic
DNA, and 2.5 U of Platinum Taq DNA polymerase (Invitrogen) or Pfu Turbo
DNA polymerase (Stratagene). RT-PCR was conducted using the SuperScript
III one-step RT-PCR system with Platinum Taq DNA polymerase (Invitrogen).
An RT-PCR mixture lacking the reverse transcriptase was included as a negative
control. Real-time qRT-PCR was performed as described previously (22) using
gene-specific primers.
Primer extension. The transcription start of the Cj0369c-cmeR operon was
identified by using a nonradioactive primer extension method described by Lloyd
et al. (25). A 6-carboxyfluorescein-labeled primer, CJ0369FAM (Table 2), was
used in the reaction. The previously described method was used without any
modifications except that an ABI 3730 DNA sequencer (Applied Biosystems)
with GeneScan 500 ROX internal lane standards (Applied Biosystems) was
used to analyze the samples. The sizes of the cDNA fragments were determined
using the GeneScan analysis software (version 3.1; Applied Biosystems).
Expression of cmeR using a shuttle vector. Primers 370F and 368R3 (Table 2
and Fig. 1A) were used in PCR to amplify a 2.2-kb fragment containing cmeR,
Cj0369c, and the upstream sequence of Cj0369c. This fragment was cloned into
shuttle vector pRY107 (52) using the restrictions sites in the primers, resulting in
plasmid pRYC7 (Table 1 and Fig. 1B). To determine if there is an internal
promoter within Cj0369c that drives the expression of cmeR, primers 369F and
368R (Table 2 and Fig. 1A) along with VentR DNA polymerase (New England
Biolab) were used in PCR to amplify the operon without the upstream sequence
of Cj0369c. The amplified fragment was subsequently cloned into the SmaI site
of pRY107 to create pRYC1 (Table 1 and Fig. 1B). Compared with pRYC7,
pRYC1 lacks the promoter region of Cj0369c (Fig. 1B). Both pRYC7 and
pRYC1 were sequenced, and no mutations were detected in the cloned DNA. By
conjugation, the plasmid constructs were introduced into 11168cmeR, resulting
in C. jejuni strains 11168cmeR and 11168cmeRC1, respectively (Table 1).
The pRYC7 plasmid was also conjugated into 11168W7cmeR, generating
11168W7cmeR (Table 1). The expression of cmeR from these C. jejuni con-
structs was determined by SDS-polyacrylamide gel electrophoresis (PAGE) and
immunoblotting using rabbit anti-recombinant CmeR (rCmeR) polyclonal anti-
sera.
Production of rCmeR and rCj0561c and their antibodies. Full-length six-His-
tagged rCmeR of NCTC 11168 was produced in E. coli by using the pQE30
(Qiagen) vector and the method described by Lin et al. (21). The pQE30 vector
was also used to express six-His-tagged recombinant Cj0561c (rCj0561c). Briefly,
a portion of the coding sequences of Cj0561c was amplified by using the Pfu
polymerase with primers 561clF and 561clR (Table 2). The PCR product was
digested with BamHI and SmaI, which recognized the restriction sites embedded
in the primers, and ligated to the pQE30 plasmid predigested with the same
enzymes. The recombinant plasmids were electroporated into E. coli M15 (Qiagen).
Transformants were selected on LB agar plates containing 30 g/ml of
kanamycin and 100 g/ml of ampicillin. The plasmids were sequenced, and no
TABLE 2. Key oligonucleotide primers used in this study
Primer Sequence (5–3)a
370F .................................TTGTCTAGAGGCACAGTCCTCACCACCTT
368R3...............................AAAGTCGACTTTAAGCTTTGGAGCTATTG
369F .................................ATGCAAGGACACATTACAAACTATACAAAAA
AACGA T
368R.................................CATCATAATCACTGACAAGTTTAGCAGGGTAA
CJ0369FAM....................CACACCAAATTCTTCCACCTAAAGTTGTAA
561clF ..............................AGGGATCCGTAGAATTTCAAGAAGGTTTTA
561clR..............................ATCCCCGGGTTAGAATTTATATCCTATACCA
561UF..............................TGAAAGTGCGATAATAGGCATA
561UR .............................AAGGATCCGCACCCACACCTATGCTTAAAT
561LF...............................AGTCTAGAATATGAAGCAGTAGGAACTGAT
561LR ..............................TGTTTAAATGTTAGCGATGAGA
ChlU ................................ACGGATCCAAAGAGTGACCGCCGAGA
ChlL .................................ACTCTAGACAGTGCGACAAACTGGGA
561PF...............................ACGGATCCATAGCTCGTTCTAAATCCAAGT
561PR ..............................ACTCTAGACCACACCTATGCTTAAATTTCC
MGCJ0368-F1 ................CTACAGCTTCTGGTTGATTG
MGCJ0369-R2................CGCGTTCTAAGGTTCATTAT
a The underlined sequences are restriction sites in the primers.
VOL. 190, 2008 GENES REGULATED BY CmeR IN CAMPYLOBACTER 1881
mutations were detected in the cloned sequence. rCj0561c was purified using
an Ni-nitrilotriacetic acid column (Qiagen) by following the manufacturer’s
instructions. The purified rCmeR and rCj0561c were resuspended in phos-
phate-buffered saline and emulsified with an equal volume of incomplete
Freund’s adjuvant (Sigma). Each antigen was subcutaneously injected into
two New Zealand White rabbits (100 g of protein/rabbit). Each rabbit
received two additional booster immunizations at 2-week intervals. The rab-
bits were bled 21 days after the last injection. Pre- and postimmune serum
samples were analyzed by immunoblotting.
Construction of an isogenic Cj0561c mutant. Two separate fragments of the
coding sequence of Cj0561c and its flanking genes were amplified using the Taq
polymerase (Promega) with primer pairs 561UF/561UR and 561LF/561LR (Ta-
ble 2). A chloramphenicol resistance cassette (cat) was amplified with the Pfu
polymerase (Stratagene) from the pUOA18 plasmid (46) using primers ChlU
and ChlL (Table 2). The amplified DNA fragments of Cj0561c and the cat
cassette were digested with BamHI and XbaI (Table 2 shows the restriction sites
in the primers) and were purified with a PCR clean-up kit (Qiagen). The digested
Cj0561c DNA fragments were ligated to the cat cassette by using T4 DNA ligase
(Promega). As a result, the cat cassette was flanked by the Cj0561c fragments.
The ligated product was purified by agarose gel electrophoresis and then cloned
into the pGEM-T vector (Promega). The plasmid construct was transformed into
E. coli JM109. Then the plasmid construct was purified from E. coli and intro-
duced into C. jejuni 11168W7 via electroporation. Insertional mutants were
selected on MH agar plates with 4 g/ml of chloramphenicol, and the double
crossover in the 11168W7561 mutant was confirmed by PCR. This mutation
resulted in deletion of 609 bp of the coding sequence from Cj0561c and simul-
taneous insertion of the cat gene into the same location.
SDS-PAGE and immunoblotting. C. jejuni proteins were separated by SDS-
PAGE and immunoblotted using anti-CmeR and anti-Cj0561c antibodies as
described previously (23).
Construction of transcriptional fusion. The promoter region of Cj0561c was
amplified from C. jejuni 11168W7 genomic DNA by using the Pfu polymerase
with primers 561PF and 561PR (Table 2). The amplified DNA was digested with
BamHI and XbaI and cloned into the pMW10 plasmid (48), leading to tran-
scriptional fusion of the Cj0561c promoter with the promoterless lacZ gene. The
ligation mixture was transformed into E. coli DH5	 cells. The plasmid with the
transcriptional fusion was designated pMW561 (Table 1). PCR and DNA se-
quencing were performed to verify the desired fusion and the lack of mutations
in the cloned promoter DNA in pMW561, which was subsequently transferred to
C. jejuni 11168W7 and 11168W7cmeR using the triparental conjugation
method reported previously (29).
-Galactosidase assay and induction of Cj0561c by bile salts. The 
-galacto-
sidase assay was performed as described previously (21). To compare the pro-
moter activities of Cj0561c in 11168W7 and 11168W7cmeR, these two strains
carrying pMW561 were grown in MH broth overnight, and the cultures were
harvested in order to measure 
-galactosidase activity. To measure the induction
of Cj0561c by bile salts, C. jejuni 11168W7 carrying pMW561 was grown under
microaerobic conditions in MH broth or MH broth supplemented with cholic
acid (2.0 mg/ml) and taurocholic acid (4.0 mg/ml) for 16 h. The same growth
conditions were also used for 11168W7cmeR carrying pMW561 to determine if
Cj0561c was further induced by bile salts in the cmeR mutant. The 
-galactosi-
dase activities in the cultures were then measured to determine if bile salts
affected transcription of Cj0561c. The concentrations of the bile salts used in the
cultures were below the minimal concentrations that inhibit 11168W7. 11168W7
containing empty vector pMW10 was used as the background control for 
-ga-
lactosidase activity.
Chicken colonization experiments. One-day-old broiler chickens were ob-
tained from a commercial hatchery. The chickens were negative for C. jejuni as
determined by culturing cloacal swabs prior to use in the study. Nonmedicated
feed and water were given ad libitum to the chickens. To determine if Cj0561c
contributes to Campylobacter colonization in chickens, three groups of chickens
were inoculated when they were 3 days old with 11168W7 (group 1),
11168W7561 (group 2), and 1:1 mixture of these two strains (group 3). Inoc-
ulation was performed via oral gavage using a dose of approximately 106 CFU of
bacteria per bird. For groups 1 and 2, five birds from each group were euthanized
and cecal contents were collected on days 3, 6, and 9 postinoculation (p.i.). For
group 3, the 12 birds inoculated were sampled on days 3, 6, and 9 p.i. using
cloacal swabs. The feces from each bird were weighed and diluted in MH broth.
The diluted samples were cultured on MH agar plates with Campylobacter-
specific selective supplements (Oxoid, United Kingdom) for colony counting. For
the group 3 fecal samples, duplicate plating of each sample on MH agar plates
with supplements and on chloramphenicol (4 g/ml)-containing plates was per-
formed to determine the total Campylobacter number and the 1168W7561
number for each sample. The plating media were tested prior to use to ensure
that they supported the growth of the mutant strain. The number of CFU per
gram of feces was calculated for each chicken and was used as an indicator of the
colonization level.
To determine the role of CmeR in chicken colonization, four groups of birds
(15 birds per group) were inoculated with 11168W7 (group 1), 11168W7cmeR
(group 2), 11168W7cmeR (group 3), and 1:1 mixture of 11168W7 and
11168W7cmeR (group 4). Each bird received approximately 106 CFU of C.
jejuni via oral gavage when it was 4 days old. Five chickens from each group were
FIG. 1. Identification of the transcription unit of the Cj0369c-cmeR operon. (A) Genomic organization and sequence features of the Cj0369c-
cmeR operon. ORFs are indicated by large arrows. The gene designations are indicated under the arrows. The bent arrows indicate the locations
and orientations of the primers used in PCR for cloning the operon. Part of the intergenic sequence is shown above the ORFs. The putative
ribosome-binding site is indicated by bold type. The inverted repeat sequences are underlined. The start codon (ATG) of Cj0369c is indicated by
lowercase letters. The transcription start site of the Cj0369c-cmeR operon is indicated by an asterisk. The 10, 16, and 35 sequences are
overlined. (B) Diagram of the two plasmid constructs used for mapping the promoter for cmeR. The ORFs correspond to those in panel A.
(C) Immunoblot analysis of CmeR from various C. jejuni strains using anti-rCmeR antibodies. Lanes 1 to 4 contained whole-cell lysates from
wild-type strain NCTC 11168, 11168cmeR carrying pRY107 (vector control), 11168cmeR carrying pRYC7, and 11168cmeR carrying pRYC1,
respectively.
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sacrificed on days 3, 6, and 9 p.i., and the cecal contents were collected for
culturing Campylobacter. For groups 1 to 3, the fecal material was weighed,
serially diluted, and plated onto MH agar plates containing Campylobacter-
specific growth supplements and selective agents. For group 4, each fecal sample
was cultured using two types of plates: the conventional selective plates for
counting total Campylobacter colonies and the same plates containing 4 g/ml of
chloramphenicol for counting colonies of 11168cmeR. All of the plating media
were pretested for suitability to recover the various strains inoculated into chick-
ens. The level of colonization was expressed as CFU/g of feces. Representative
Campylobacter colonies recovered from each group of chickens were analyzed by
PCR and by growth on appropriate antibiotic-containing media. The chicken
experiment was conducted twice with the same design.
In both experiments, the detection limit of the plating methods was 100 CFU/g
of feces. A bird from which no Campylobacter colonies were detected was con-
sidered negative and assigned a value of 0 for the purpose of calculating means
and for statistical analysis. The significance of differences in the levels of colo-
nization between the group inoculated with a mutant strain and the group
inoculated with the wild-type strain was determined using Student’s t test,
Welch’s t test to allow for nonconstant variation across treatment groups, and the
Wilcoxon rank-sum test to allow for nonnormality. For all comparisons discussed
in Results, the conclusions for all three tests were the same at a significance level
of 0.05. For clarity and brevity, we present only the P values for the Wilcoxon
rank-sum test in Results.
Microarray data accession number. The microarray data have been deposited
in the NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) un-
der accession number GSE5412.
RESULTS
Identification of the native promoter of cmeR. To facilitate
the characterization of cmeR, we identified the promoter that
drives the transcription of this gene in C. jejuni. As illustrated
in Fig. 1A, Cj0369c and cmeR are tandemly positioned on the
C. jejuni chromosome. The two open reading frames (ORFs)
overlap by 14 nucleotides, suggesting that they are likely co-
transcribed. To examine this possibility, RT-PCR was per-
formed using total RNA from NCTC 11168 and primers
MGCJ0368-F1 and MGCJ0369-R2 (Table 2) that span the
junction of Cj0369c and cmeR. A positive RT-PCR product
was obtained from the RNA sample (data not shown), while
control RT-PCRs (with no reverse transcriptase) yielded no
products, suggesting that cmeR and Cj0369c are cotranscribed.
There is a single predicted RpoD promoter in front of Cj0369c,
and there is no predicted promoter in front of cmeR (34). To
determine the location of the promoter that drives the expres-
sion of cmeR, pRYC7 and pRYC1 (Fig. 1B) were introduced
into 11168cmeR, and expression of cmeR from the plasmid
constructs was detected by immunoblotting using anti-rCmeR
antibodies. As shown in Fig. 1C, a CmeR-specific product was
detected in 11168cmeR transformed with pRYC7 (lane 3)
but not in 11168cmeR transformed with pRYC1 (lane 4).
This result indicated that there is no promoter in the coding
sequence of Cj0369c and that cmeR is expressed from the
promoter in front of Cj0369c.
In order to locate the transcription start of the Cj0369c-
cmeR operon, primer extension was performed using primer
CJ0369FAM (Table 2) and total RNA extracted from strain
NCTC 11168. An electropherogram revealed a single distinct
6-carboxyfluorescein peak corresponding to a cDNA fragment
consisting of 283 bases (data not shown). This result mapped
the transcription start site to the guanine 30 nucleotides up-
stream of the ATG start codon of Cj0369c (Fig. 1A). Based on
the results of the primer extension analysis and the predicted
promoter consensus sequences (48), the 10, 16, and 35
sites of the promoter were identified (Fig. 1A). Interestingly,
there was an inverted repeat between the 10 site and the
ribosome-binding site (Fig. 1A), suggesting a potential regula-
tory mechanism for this operon.
Identification of genes regulated by CmeR. It has been well
established that CmeR functions as a repressor for cmeABC
(21), but it was not known if CmeR regulates other genes in C.
jejuni. To examine this possibility, we compared the transcrip-
tome of strain NCTC 11168 with that of 11168cmeR using a
DNA microarray. Mutation of cmeR did not affect C. jejuni
growth in MH broth, and the mutant and wild-type strain
showed comparable growth kinetics (data not shown). Based
on the results of the DNA microarray analysis, 27 genes had P
values of 0.05 and were differentially expressed 2-fold in
the wild type and 11168cmeR (Table 3). Cj0087 showed a
1.97-fold increase (P 0.011) and is also listed in Table 3. The
Q values for these 28 genes indicated that the FDR was ap-
proximately 20%. However, real-time qRT-PCR experiments
using independent RNA samples confirmed 27 of the 28 genes
identified by the DNA microarray (Table 3). Thus, the actual
proportion of false-positive results appeared to be less than
20% in this case. The expression of Cj0583, for which the
microarray showed a 6.6-fold increase, was not confirmed by
real-time RT-PCR (Table 3). To confirm that the changes were
associated with mutation of cmeR, we compared the expression
of 14 representative genes in 11168cmeR (11168cmeR
complemented with pRYC7) and wild-type strain NCTC
11168. The complementation either partially or completely
restored the levels of expression of the tested genes to the
wild-type levels (Table 3).
Of the 28 affected genes, 11 were upregulated and the others
were downregulated in 11168cmeR (Table 3). The identified
genes encode membrane transporters (Cj0035c, Cj0366c,
Cj0561c, and Cj1619), proteins involved in C4-dicarboxylate
transport or utilization and metabolism (Cj0087, Cj0088,
Cj0671, Cj0437, Cj0264c, and Cj0119), enzymes for capsular poly-
saccharide biosynthesis (Cj1424c, Cj1426c, Cj1427c, Cj1428c,
Cj1429c, Cj1430c, and Cj1432c), periplasmic proteins or lipopro-
teins (Cj0089, Cj0091, Cj0092, Cj0628/Cj0629, and Cj0854c), a
putative transcriptional factor (Cj1563c, a MerR homolog), a
putative iron-binding protein (Cj0241c), a putative purine nucle-
oside triphosphate pyrophosphatase (Cj1374c), and hypothetical
proteins (Cj0040 and Cj0583). Cj0628 and Cj0629 were originally
annotated as two separate genes (32), but recent work showed
that these two genes form a single ORF encoding an autotrans-
porter protein (2).
Differential expression of the identified genes in 11168W7
and 11168W7cmeR. The DNA microarray analysis was per-
formed with strain NCTC 11168, whose genomic sequence was
used to manufacture the microarray slides used in this study.
However, this sequenced strain is a poor colonizer in animals.
To determine the role of CmeR and the genes that it regulates
in colonization, we introduced the cmeR mutation into
11168W7 (Table 1), a highly mobile variant of NCTC 11168
and an excellent colonizer of the chicken host. Strains NCTC
11168 and 11168W7 were indistinguishable by pulsed-field gel
electrophoresis (data not shown). The cmeR mutation in
11168W7 did not change the growth characteristics because
11168W7 and11168W7cmeR grew similarly in MH broth
(data not shown). Using real-time RT-PCR, we confirmed that
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several representative genes were differentially expressed in
11168W7cmeR and 11168W7 (Table 4). For example, all six
upregulated transporter genes in 11168cmeR (Table 3) were
also upregulated in 11168W7cmeR (Table 4). In both cases,
Cj0561c showed the greatest increase in expression in the
cmeR mutant background. This result not only further vali-
dates the findings of the DNA microarray analysis but also
indicates that the null mutation of cmeR resulted in similar
patterns of changes in NCTC 11168 and 11168W7.
Confirmation of Cj0561c regulation by CmeR. As shown by
the DNA microarray and real-time RT-PCR analyses (Tables
3 and 4), the expression of Cj0561c was greatly upregulated in
the CmeR mutant, suggesting that CmeR represses the expres-
sion of this gene. Cj0561c encodes a probable periplasmic
protein and is transcribed divergently from the flanking genes
(Fig. 2A). Although the Cj0561c protein does not show signif-
icant sequence homology to proteins with known functions, it
has a single N-terminal hydrophobic domain and a large gen-
erally hydrophilic C-terminal region, a structural feature of
periplasmic membrane fusion proteins involved in transport
across membranes (7). Analysis of the intergenic sequence of
Cj0561c revealed the presence of the known CmeR-binding
site (Fig. 2A), an inverted repeat of TGTAAT (21). In contrast
TABLE 3. Differentially expressed genes (2-fold changes) in 11168cmeR identified by DNA microarray and real-time qRT-PCR
Function category and description Gene P value
Fold change
determined by
microarray
Fold change
determined by
qRT-PCRa
Complementationb
Membrane transporters
Probable efflux transporter belonging to
the MF family
Cj0035c 4.03E-02 2.5 8.4 1.6
Resistance-nodulation-division-type
transporter (cmeB)
Cj0366c 1.67E-03 7.8 6.8 2.3
Probable membrane fusion protein Cj0561c 4.62E-03 11.2 109.0 22.0
Probable sugar transport protein Cj1619 2.28E-02 2.2 1.6 NT
C4-dicarboxylate transport and utilization
Aspartate-ammonia lyase (aspA) Cj0087 1.10E-02 2.0 3.0 1.4
C4-dicarboxylate transporter (dcuA) Cj0088 1.60E-02 2.3 6.0 1.4
C4-dicarboxylate transporter (dcuB) Cj0671 2.62E-02 2.4 6.2 1.1
Succinate dehydrogenase (sdhA) Cj0437 2.67E-02 2.7 2.2 NT
DMSO/TMAO reductase Cj0264c 6.61E-03 2.0 3.3 NT
Probable cysteine hydrolase Cj0119 4.62E-03 2.0 1.6 NT
Periplasmic proteins and lipoproteins
Probable lipoprotein Cj0089 4.19E-02 2.1 2.0 1.3
Probable lipoprotein Cj0091 2.00E-02 4.3 4.5 1.2
Probable periplasmic protein Cj0092 8.72E-03 2.6 1.9 NT
Autotransporter protein (capA) Cj0628/Cj0629 2.57E-02 2.2 2.5 NT
Probable periplasmic protein Cj0854c 3.69E-02 2.1 4.0 1.5
Capsule biosynthesis
Probable phosphoheptose isomerase Cj1424c 5.78E-03 4.2 10.2 3.2
Probable methyltransferase Cj1426c 4.45E-02 2.4 5.4 NT
Sugar-nucleotide epimerase/dehydratease Cj1427c 6.02E-03 4.2 7.4 3.6
Putative fucose synthetase Cj1428c 1.46E-02 4.1 8.0 2.8
Hypothetical protein Cj1429c 5.62E-03 4.3 7.4 NT
Nucleotide-sugar epimerase/dehydratase Cj1430c 3.66E-03 5.1 5.2 2.0
Putative sugar transferase Cj1432c 1.90E-02 3.2 8.1 4.5
Other proteins
Hypothetical protein Cj0040 6.39E-03 2.1 2.5 NT
Probable transcriptional regulator (merR
homolog)
Cj1563c 6.98E-03 2.2 3.8 NT
Hypothetical protein Cj0583 6.88E-05 6.6 1.3 NT
Probable iron-binding protein Cj0241c 4.42E-02 2.5 4.3 NT
Probable purine nucleoside triphosphate
pyrophosphatase
Cj1374c 3.08E-02 4.8 1.5 NT
a Mean of three independent experiments.
b Fold changes in 11168cmeR compared with NCTC 11168. The values are means of three independent qRT-qPCR experiments. NT, not tested.
TABLE 4. Differential expression of selected genes in
11168W7cmeR and 11168W7
Gene Fold changea
Cj0561c............................................................................................126
Cj0035c............................................................................................ 8.0
Cj0366c............................................................................................ 4.1
Cj0087 ............................................................................................. 6.3
Cj0088 ............................................................................................. 2.8
Cj0671 ............................................................................................. 5.3
Cj0089 .............................................................................................3.3
Cj0091 .............................................................................................4.4
a Mean of three independent qRT-PCR experiments.
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to the promoter of cmeABC, which has one inverted repeat
(21), there are two inverted repeats (IR1 and IR2) (Fig. 2A) in
the promoter region of Cj0561c, suggesting that CmeR may
bind to more than one site in the promoter of Cj0561c.
To confirm the regulation of Cj0561c by CmeR, the pro-
moter region of Cj0561c was fused with the promoterless lacZ
gene in the pMW10 plasmid. The transcriptional fusion con-
struct (pMW561) was introduced into C. jejuni 11168W7 and
11168W7cmeR. As shown in Fig. 2B, the base level of tran-
scription of Cj0561c in 11168W7 was low, but its expression
was approximately 46-fold greater in 11168W7cmeR. In ad-
dition, immunoblotting was performed to compare the produc-
tion of Cj0561c in 11168W7 and the production of Cj0561c in
11168W7cmeR. As shown in Fig. 2C, Cj0561c was barely
detected by anti-Cj0561c antibodies in 11168W7 but was
greatly overexpressed in 11168W7cmeR. These results are
consistent with the findings of the DNA microarray and real-
time RT-PCR analyses and strongly indicate that CmeR inhib-
its the expression of Cj0561c.
Cj0561c is inducible by bile salts. Our previous studies
showed that bile compounds, which are normally present in
animal intestinal tracts, inhibit the binding of CmeR to the
promoter of cmeABC and induce the expression of this efflux
operon (22). Since CmeR also represses Cj0561c, we suspected
that bile salts may also induce the expression of Cj0561c. This
possibility was investigated using transcriptional fusion con-
struct pMW561 (Table 1). Strain 11168W7 carrying pMW561
was cultured in the presence or absence of bile salts. Compared
with the base level of expression in MH broth, the transcription
of Cj0561c showed 17- and 28-fold increases in the presence of
cholic acid and taurocholic acid, respectively (Fig. 3A). This
finding indicates that Cj0561c is strongly induced by bile salts.
To determine if the induction is via the CmeR regulatory
pathway, 11168W7cmeR carrying pMW561 was also cultured
in the presence of bile salts. As shown in Fig. 3B, the base level
of expression of Cj0561c in 11168W7cmeR was high due to
FIG. 2. Regulation of Cj0561c by CmeR. (A) Genomic location and sequence features of the promoter region of Cj0561c. The inverted repeats
(IR1 and IR2), representing the known binding site of CmeR, are indicated by uppercase letters and arrows. The start codon (TTG) of Cj0561c
is indicated by bold type. The putative ribosome-binding site (RBS) is underlined. (B) Transcriptional fusion (
-galactosidase assay) demonstrating
the enhanced expression of Cj0561c in the cmeR mutant (11168W7cmeR). (C) Immunoblotting with the anti-Cj0561c antibody showing the
expression levels of Cj0561c (indicated by an arrowhead) in 11168W7 (lane 2) and 11168W7cmeR (lane 3). The same amount (10 g) of total
protein was loaded in lanes 2 and 3. Lane 1 contained protein size standards.
FIG. 3. Induction of Cj0561c by bile salts. C. jejuni 11168W7 car-
rying pMW561 (A) and 11168W7cmeR carrying pMW561 (B) were
grown in MH broth or MH broth supplemented with cholic acid (CA)
or taurocholic acid (TCA). The promoter activity of Cj0561c was
measured by the 
-galactosidase assay. The bars and error bars indi-
cate the means and standard deviations of triplicate measurements,
respectively.
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loss of the repressor. When bile salts were added in the culture
media, the transcription of the Cj0561c promoter showed only
1.5- and 2.0-fold increases with cholic acid and taurocholic
acid, respectively (Fig. 3B), which were much less than the
changes in the wild-type background. This result indicates that
the induction of expression of Cj0561c by bile salts occurs
predominantly through the CmeR pathway.
Mutation of Cj0561c does not affect the susceptibility to
antimicrobial compounds. Compared with 11168W7, 11168
W7561 did not show any changes in the susceptibility to
various antibiotics, toxic compounds, and heavy metals tested
in this study, including ciprofloxacin, erythromycin, ampicillin,
cephalothin, cefoperazone, cefotaxime, gentamicin, ethidium
bromide, polymyxin B, vancomycin, tetracycline, rifampin, cho-
lic acid, taurocholic acid, SDS, CuSO4, ZnCl2, NiCl2, MnCl2,
and CoCl2. This finding suggests that under in vitro culture
conditions, Cj0561c is not involved in Campylobacter resistance
to antimicrobials.
Role of Cj0561c in in vivo colonization. The strong induction
of Cj0561c by bile salts suggests that it may be involved in the
adaptation of C. jejuni in the intestinal environment. To exam-
ine this possibility, chickens were colonized with 11168W7 and
its isogenic mutant 11168W7561. When separately inoculated
into chickens, the two strains colonized the birds extensively,
and no significant differences (P  0.05) were observed in the
levels of colonization between the two groups (Fig. 4A). The
Campylobacter colonies recovered from the chickens inocu-
lated with 11168W7561 were also transferred to plates con-
taining chloramphenicol (4 g/ml), and all of the colonies
tested grew on the plates, indicating that the cat insertion in
Cj0561c was stable in chickens. Notably, when the two strains
were coinoculated into a group of chickens, the colonization
level of 11168W7561 was significantly (P  0.01) less than
that of the wild-type strain on days 3, 6 and 9 p.i. (Fig. 4B). This
result indicates that Cj0561c contributes to Campylobacter col-
onization and is required for the full fitness of this organism in
the intestinal tract of chickens.
CmeR is required for optimal colonization in chickens. The
pleiotropic effect of CmeR on gene expression in C. jejuni
suggests that it may be an important factor in Campylobacter
adaptation in the animal host. To examine this possibility,
strains 11168W7, 11168W7cmeR, and 11168W7cmeR
were inoculated into four groups of chickens (15 chickens per
group). By day 3 p.i., all four groups of chickens were colonized
by Campylobacter. There were approximately 1- to 2-log reduc-
tions on days 3 and 6 p.i. in the mean number of CFU/g of
feces in the 11168W7cmeR-inoculated group compared to
the 11168W7 group (Fig. 5A). The difference was not statisti-
cally significant (P  0.222) on day 3 p.i. but was significant
(P  0.012) on day 6 p.i. On day 9 p.i., the two groups showed
similar levels of colonization (P  0.421). To examine the
stability of the insertional mutation in cmeR, representative
Campylobacter colonies recovered from the chickens inocu-
lated with 11168W7cmeR were transferred to plates contain-
ing chloramphenicol (4 g/ml) and analyzed by PCR using
primers that detect the cat insertion in cmeR. All of the tested
colonies grew well on the plates and harbored the cat cassette
inserted into cmeR (data not shown). This result indicated the
insertional mutation in 11168W7cmeR was stable during in
vivo colonization and was able to confer resistance to 4 g/ml
of chloramphenicol, which was used for differential plating in
the group with a mixed infection. Surprisingly, the levels of
Campylobacter colonization in the group inoculated with
11168W7cmeR were similar to the levels of Campylobacter
colonization in the group inoculated with 11168W7cmeR
(Fig. 5A), indicating that the complementation did not restore
colonization. However, PCR and plating analysis of the
Campylobacter isolates from this group revealed that 13 of 15
randomly selected colonies (5 colonies from each sampling
time point) lacked the pRYC7 plasmid, suggesting that the
complementing plasmid was lost during colonization. The loss
of the plasmid occurred quickly because the majority (4/5) of
the tested colonies for day 3 p.i. were already negative with
pRYC7. In the group inoculated with a 1:1 mixture of
11168W7 and 11168W7cmeR, the mutant strain was increas-
ingly outnumbered by the wild-type strain from day 3 p.i. to day
FIG. 4. Effect of the Cj0561c mutation on colonization of chickens
by C. jejuni. The experiment included three groups of birds. The first
two groups of birds were inoculated with 11168W7 and 11168W7561
(A). The third group was infected with a 1:1 mixture of the two strains
(B). Each symbol indicates the log number of CFU/g of feces for a
single chicken. The horizontal bars indicate the means of groups at the
indicated times. The detection limit of the plating method is about 100
CFU/g of feces. DPI, days postinoculation.
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9 p.i. (Fig. 5B). The difference between the two populations
was not statistically significant on day 3 p.i. (P 0.204) but was
significant on day 6 p.i. (P  0.01) and day 9 p.i. (P  0.011).
In fact, 11168W7cmeR was not detected in the majority of
the chickens necropsied on days 6 and 9 p.i. The chicken
experiment was repeated with the same design, and similar
results were obtained (data not shown). These findings, espe-
cially the results for the group with a mixed infection, clearly
indicate that CmeR is required for optimal colonization of
chickens by Campylobacter.
DISCUSSION
This study demonstrates that CmeR, in addition to control-
ling the expression of the multidrug efflux pump CmeABC,
modulates the expression of multiple genes with diverse phys-
iological functions in C. jejuni. This finding indicates that
CmeR is a pleiotropic regulator in C. jejuni. We also demon-
strated the tight regulation of Cj0561c by CmeR and the im-
portant role of CmeR in Campylobacter colonization in chick-
ens. Our findings reveal new functions for this transcriptional
regulator and define its importance in governing Campy-
lobacter adaptation to in-host environments. Based on the new
results and previous findings (12, 21, 22), we propose a func-
tional model for CmeR in which it binds to target DNA via its
N-terminal HTH motif and interacts with various inducing
signals via its large ligand-binding pocket located in the C-
terminal region. Interaction with the inducing signals presum-
ably triggers a conformational change in the DNA-binding
domain and thus affects the expression of CmeR-regulated
genes. We have previously shown that bile salts are inducers of
CmeR, but it is possible that CmeR also interacts with other
unidentified signals in the intestinal tract, which will be exam-
ined in future studies. At this stage, we do not know if CmeR
interacts with the TCR systems identified in C. jejuni. How-
ever, the presence of an inverted repeat between the 10
sequence and the ribosome-binding site of the Cj0369c-cmeR
operon (Fig. 1A) suggests that this operon is regulated by an
unidentified mechanism.
The genes identified by DNA microarray analysis (Table 3)
can be directly or indirectly regulated by CmeR. The known
binding sequence of CmeR was identified in the promoter
regions of cmeABC and Cj0561c but was not present in the
intergenic regions of other CmeR-regulated genes. Alignment
of the intergenic regions of the CmeR-regulated genes did not
reveal a consensus sequence potentially bound by CmeR (data
not shown). However, repeat sequences different from the
known CmeR-binding site are present in some of the inter-
genic regions. The absence of a consensus binding sequence in
the intergenic sequences does not exclude the possibility that
CmeR may have certain flexibility in recognizing target se-
quences and hence can interact with multiple promoters in
C. jejuni. Alternatively, some of the identified genes may be
indirectly regulated by CmeR via unidentified secondary reg-
ulatory pathways.
In Staphylococcus aureus, the MgrA protein serves a pleio-
tropic global regulator that modulates the expression of
multidrug efflux pumps, type 8 capsular polysaccharide, and
extracellular proteins (27, 43, 44). MgrA contains a typical
HTH DNA-binding motif and is a member of the MarR family
of transcriptional regulators. Similar to CmeR, MgrA also
functions as both a repressor and an activator for various genes
in Staphylococcus (16, 27, 43). A recent DNA microarray study
indicated that MgrA affects the expression of 355 genes in
multiple functional categories in S. aureus (26). These findings
plus the results from this study suggest that the simultaneous
control of multidrug efflux pumps and other physiological
pathways by a transcriptional regulator may be a common
mechanism that facilitates bacterial adaptation to various en-
vironment changes.
In the DNA microarray, we arbitrarily chose a twofold or
greater change as one of the cutoff criteria with the intention of
selecting for biologically significant changes in gene expression.
If the criterion was lowered to 1.5-fold, 61 genes (P  0.05;
FDR, 20%) were identified by the DNA microarray (data
FIG. 5. Inactivation of CmeR reduces C. jejuni colonization in
chickens. The experiment included four groups of birds. The first three
groups were inoculated with 11168W7, 11168W7cmeR, and 11168
W7cmeR (A). The fourth group was inoculated with a 1:1 mixture
of 11168W7 and 11168W7cmeR (B). Each symbol indicates the log
number of CFU/g of feces for a single chicken. The horizontal bars
indicate the means of groups at the indicated times. The detection
limit of the plating method is approximately 100 CFU/g of feces. DPI,
days postinoculation.
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not shown). Thus, the gene list in Table 3 represents the
minimum number of genes affected by CmeR, and it is likely
that additional genes outside the cutoff are also affected by the
mutation in CmeR. One of the limitations of the DNA mi-
croarray technology is the lack of simultaneous detection of all
genes in an operon. Although it is known that cmeA, cmeB, and
cmeC are cotranscribed and are all upregulated in the cmeR
mutant (21, 23), only cmeB was identified in 11168cmeR by
the microarray method (Table 3). Subsequent tests using real-
time qRT-PCR confirmed that cmeA (10-fold) and cmeC (15-
fold) were also upregulated in 11168cmeR. The lack of si-
multaneous detection of all genes in an affected operon by the
DNA microarray has also been observed in other studies (40,
47) and suggests that DNA microarray analysis has a lower
sensitivity than real-time qRT-PCR. Interestingly, Cj0583
showed a 6.6-fold change in expression when the DNA mi-
croarray was used, but this was not verified by real-time RT-
PCR (Table 3). Further analysis of the microarray data indi-
cated that expression of Cj0583 was consistently upregulated
on all six slides (P  6.88E-05), which argues against the
possibility that Cj0583 was identified due to experimental er-
rors. The reason for the discrepancy between the microarray
results and the RT-PCR data for Cj0583 is unknown. In gen-
eral, the levels of changes in gene expression detected by real-
time qRT-PCR are higher than those detected by DNA mi-
croarrays (Table 3). Similar findings were reported previously
by other investigators, suggesting that a DNA microarray has a
lower dynamic range than real-time qRT-PCR (31, 39).
Several genes, including aspA (Cj0087), dcuA (Cj0088),
dcuB (Cj0671), sdhA (Cj0437), and Cj0246c, involved in C4-
dicarboxylate transport and utilization and Campylobacter ad-
aptation to oxygen-limited conditions were upregulated in the
cmeR mutant (Tables 3 and 4). The observed changes were
shown to be effects of the cmeR mutation and were not due to
the differences between NCTC 11168 and 11168W7. In previ-
ous work other investigators reported that different variants of
NCTC 11168 varied in gene expression and virulence and that
several genes involved in C4-dicarboxylate transport and utili-
zation were upregulated in the variants that are more virulent
(5, 10). Realizing that the two variants (NCTC 11168 and
11168W7) used in this study may have some differences in gene
expression, we generated a CmeR mutant with each variant
and compared each cmeR mutant with its isogenic wild-type
strain to determine gene expression and phenotypic changes.
Mutation of cmeR in both variants consistently resulted in
enhanced expression of the genes involved in C4-dicarboxylate
transport and utilization (Tables 3 and 4). In addition, the
expression level of the dcu genes was near the wild-type level
when 11168cmeR was complemented in trans by pRYC7
(Table 3). Together, these data convincingly showed that the
dcu system is affected by the cmeR mutation.
The Dcu system is considered an important mechanism for
Campylobacter adaptation to low-oxygen environments (19).
dcuA encodes an inner membrane protein responsible for the
transport of aspartate, as well as other C4-dicarboxylates,
across the cytoplasmic membrane (19). Once transported into
the cytoplasm, aspartate is converted to fumarate by aspartase
(encoded by aspA). When oxygen is limited or absent, fuma-
rate can be used as an alternative terminal electron acceptor in
the electron transport chain and supports Campylobacter
growth under such conditions (19, 37, 47). DcuB is predicted to
function as a transporter for C4-dicarboxylates (succinate and
fumarate), exchanging succinate for fumarate, which serves as
a terminal electron acceptor (37). It should be pointed out that
DcuA and DcuB in E. coli have overlapping functions and that
both can transport succinate, fumarate, malate, and aspartate
(15). The Cj0264c protein is the sole dimethyl sulfoxide
(DMSO)/trimethylamine oxide (TMAO) reductase in C. jejuni
and was shown by Sellars et al. (37) to support DMSO- or
TMAO-dependent growth under oxygen-limited conditions. It
was also speculated by Sellars et al. (37) that the reduction of
DMSO and TMAO facilitates Campylobacter survival outside
the host, such as in aquatic environments. Notably, aspA, dcuA,
dcuB, and sdhA were shown by Woodall et al. (47) to be
substantially upregulated in the chicken cecum, suggesting that
they are involved in Campylobacter adaptation to the environ-
ment in the gut. At this stage, it is not known if CmeR directly
or indirectly regulates the C4-dicarboxylate transport and uti-
lization system and if the Dcu system is regulated by multiple
mechanisms.
Capsular polysaccharide (CPS) was recently identified in C.
jejuni (3, 17, 41). Despite the advances in understanding the
structure and function of CPS, little is known about the regu-
latory mechanisms that modulate the expression of CPS in
Campylobacter (18). The CPS gene cluster in strain NCTC
11168 spans 47 kb and contains 40 genes encoding proteins
involved in CPS biosynthesis and transport across the mem-
brane (32). It is unclear if these CPS genes are cotranscribed
and if they are coordinately regulated by one or more mech-
anisms. The seven genes affected by the CmeR mutation are
located in the middle of the CPS gene cluster and are all
involved in CPS biosynthesis (Table 3). No genes involved in
CPS transport showed significant changes in 11168cmeR.
This finding suggests that the CPS biosynthesis genes may be
regulated separately from the genes with transport functions.
How CmeR modulates the expression of CPS production in C.
jejuni remains to be determined.
One of the genes affected by the CmeR mutation is Cj1563c,
which encodes a probable transcriptional regulator belonging
to the MerR family. The MerR proteins in bacteria function as
metal-responsive transcriptional factors and modulate the ex-
pression of genes involved in the efflux and detoxification of
metal ions (33). The fact that Cj1563c was upregulated in
11168cmeR suggests that CmeR represses the expression of
this putative regulator. In addition, several genes encoding
putative lipoproteins (Cj0089, Cj0091, Cj0628, and Cj0629)
and periplasmic proteins (Cj0092 and Cj0854c) were also
downregulated in 11168cmeR, but the functions of these
products are unknown.
Results of this study clearly showed that CmeR represses the
expression of Cj0561c and that this repression is alleviated in
the presence of bile salts (Fig. 2 and 3). This regulatory feature
is similar to that of CmeABC (21, 22) and is consistent with the
findings of other investigators that Cj0561c and cmeABC are
upregulated in the intestinal tract (40, 47), where bile com-
pounds are present. Although CmeR is the primary factor
controlling the expression of Cj0561c, the transcription of
Cj0561c was further induced by bile salts in the CmeR-negative
background (Fig. 3B), suggesting that a secondary CmeR-in-
dependent mechanism also modulates the expression of
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Cj0561c. Unlike CmeABC, Cj0561c does not seem to contrib-
ute to bile resistance because inactivation of Cj0561c did not
result in a change in the MICs of various bile salts (data not
shown). This difference suggests that even though both
Cj0561c and cmeABC are inhibited by CmeR and inducible by
bile compounds, they have different physiological functions.
Although the exact function of Cj0561c is unknown at present,
the reduced ability of 11168W7561 to compete with 11168W7
(Fig. 4) in chickens suggests that Cj0561c contributes to
Campylobacter adaptation in vivo.
Inactivation of cmeR led to reduced colonization of chickens
by C. jejuni, and the reduction was especially obvious in the
group with a mixed infection (Fig. 5). This result indicates that
CmeR is required for optimal colonization of C. jejuni in vivo.
The inability of complementation to restore colonization was
likely due to the loss of pRYC7 during the course of infection.
The inoculum (11168W7cmeR) was shown to contain this
plasmid (by plating on both MH agar plates and kanamycin-
containing plates) before inoculation. In addition, limited pas-
sage of 11168W7cmeR in antibiotic-free MH broth did not
result in loss of the plasmid. However, once the strain was
inoculated into chickens, the plasmid disappeared from it, sug-
gesting that pRYC7 is unstable during in vivo infection. Insta-
bility of plasmids in C. jejuni has also been reported by other
investigators (20) and represents a challenge in characterizing
gene functions in Campylobacter. Nonetheless, the coloniza-
tion defect of the CmeR mutant was reproduced in a replica
experiment (data not shown) and was also indirectly confirmed
by the results of the unsuccessful complementation due to
plasmid loss (Fig. 5). Previously, CmeABC was found to be a
key factor in Campylobacter colonization of the intestinal tract
by conferring bile resistance (24). In this work, we found that
Cj0561c also contributes to intestinal colonization (Fig. 4).
Since both cmeABC and Cj0561c were upregulated in
11168W7cmeR (Table 3), one might have expected that the
cmeR mutant strain would colonize chickens better than the
wild-type strain. But this was not the case, suggesting that
uncontrolled overexpression of cmeABC and Cj0561c is detri-
mental to Campylobacter during in vivo infection. Alterna-
tively, the colonization defect in the cmeR mutant may be due
to a loss of balance in gene expression. CmeR affects the
expression of multiple genes with diverse functions (Table 3)
and likely influences multiple physiological processes in C.
jejuni. Thus, both the functions of the individual genes and
their coordinated expression by CmeR are important for the
fitness of C. jejuni during in vivo colonization. How CmeR
interacts with its regulated genes and the various signals in the
intestinal tract warrants further investigation.
ACKNOWLEDGMENTS
This work was supported by National Institutes of Health grant
RO1DK063008.
We thank Sonia Pereira for technical assistance with the chicken
experiments and Stuart A. Thompson (Medical College of Georgia)
for providing helpful information on primer extension.
REFERENCES
1. Andersen, M. T., L. Brondsted, B. M. Pearson, F. Mulholland, M. Parker, C.
Pin, J. M. Wells, and H. Ingmer. 2005. Diverse roles for HspR in Campy-
lobacter jejuni revealed by the proteome, transcriptome and phenotypic char-
acterization of an hspR mutant. Microbiology 151:905–915.
2. Ashgar, S. S., N. J. Oldfield, K. G. Wooldridge, M. A. Jones, G. J. Irving,
D. P. Turner, and D. A. Ala’Aldeen. 2007. CapA, an autotransporter protein
of Campylobacter jejuni, mediates association with human epithelial cells and
colonization of the chicken gut. J. Bacteriol. 189:1856–1865.
3. Bacon, D. J., C. M. Szymanski, D. H. Burr, R. P. Silver, R. A. Alm, and P.
Guerry. 2001. A phase-variable capsule is involved in virulence of Campy-
lobacter jejuni 81-176. Mol. Microbiol. 40:769–777.
4. Bras, A. M., S. Chatterjee, B. W. Wren, D. G. Newell, and J. M. Ketley. 1999.
A novel Campylobacter jejuni two-component regulatory system important
for temperature-dependent growth and colonization. J. Bacteriol. 181:3298–
3302.
5. Carrillo, C. D., E. Taboada, J. H. Nash, P. Lanthier, J. Kelly, P. C. Lau, R.
Verhulp, O. Mykytczuk, J. Sy, W. A. Findlay, K. Amoako, S. Gomis, P.
Willson, J. W. Austin, A. Potter, L. Babiuk, B. Allan, and C. M. Szymanski.
2004. Genome-wide expression analyses of Campylobacter jejuni NCTC11168
reveals coordinate regulation of motility and virulence by flhA. J. Biol.
Chem. 279:20327–20338.
6. Dingle, K. E., and M. C. J. Maiden. 2005. Population genetics of Campy-
lobacter jejuni, p. 43–57. In J. M. Ketley and M. E. Konkel (ed.), Campy-
lobacter: molecular and cellular biology. Horizon Bioscience, Norfolk,
United Kingdom.
7. Dinh, T., I. T. Paulsen, and M. H. Saier. 1994. A family of extracytoplasmic
proteins that allow transport of large molecules across the outer membranes
of gram-negative bacteria. J. Bacteriol. 176:3825–3831.
8. Dudoit, S., Y. H. Yang, M. J. Callow, and T. P. Speed. 2002. Statistical
methods for identifying differentially expressed genes in replicated cDNA
microarray experiments. Stat. Sin. 12:111–139.
9. Fouts, D. E., E. F. Mongodin, R. E. Mandrell, W. G. Miller, D. A. Rasko, J.
Ravel, L. M. Brinkac, R. T. Deboy, C. T. Parker, S. C. Daugherty, R. J.
Dodson, A. S. Durkin, R. Madupu, S. A. Sullivan, J. U. Shetty, M. A. Ayodeji,
A. Shvartsbeyn, M. C. Schatz, J. H. Badger, C. M. Fraser, and K. E. Nelson.
2005. Major structural differences and novel potential virulence mechanisms
from the genomes of multiple Campylobacter species. PLoS Biol. 3:e15.
10. Gaynor, E. C., S. Cawthraw, G. Manning, J. K. MacKichan, S. Falkow, and
D. G. Newell. 2004. The genome-sequenced variant of Campylobacter jejuni
NCTC 11168 and the original clonal clinical isolate differ markedly in colo-
nization, gene expression, and virulence-associated phenotypes. J. Bacteriol.
186:503–517.
11. Gaynor, E. C., D. H. Wells, J. K. MacKichan, and S. Falkow. 2005. The
Campylobacter jejuni stringent response controls specific stress survival and
virulence-associated phenotypes. Mol. Microbiol. 56:8–27.
12. Gu, R., C. C. Su, F. Shi, M. Li, G. McDermott, Q. Zhang, and E. W. Yu. 2007.
Crystal structure of the transcriptional regulator CmeR from Campylobacter
jejuni. J. Mol. Biol. 372:583–593.
13. Hendrixson, D. R. 2006. A phase-variable mechanism controlling the Campy-
lobacter jejuni FlgR response regulator influences commensalism. Mol. Mi-
crobiol. 61:1646–1659.
14. Hofreuter, D., J. Tsai, R. O. Watson, V. Novik, B. Altman, M. Benitez, C.
Clark, C. Perbost, T. Jarvie, L. Du, and J. E. Galan. 2006. Unique features
of a highly pathogenic Campylobacter jejuni strain. Infect. Immun. 74:4694–
4707.
15. Janausch, I. G., E. Zientz, Q. H. Tran, A. Kroger, and G. Unden. 2002.
C-4-dicarboxylate carriers and sensors in bacteria. Biochim. Biophys. Acta
Bioenergetics 1553:39–56.
16. Kaatz, G. W., R. V. Thyagarajan, and S. M. Seo. 2005. Effect of promoter
region mutations and mgrA overexpression on transcription of norA, which
encodes a Staphylococcus aureus multidrug efflux transporter. Antimicrob.
Agents Chemother. 49:161–169.
17. Karlyshev, A. V., M. V. McCrossan, and B. W. Wren. 2001. Demonstration
of polysaccharide capsule in Campylobacter jejuni using electron microscopy.
Infect. Immun. 69:5921–5924.
18. Karlyshev, A. V., O. L. Champion, G. W. P. Joshua, and B. W. Wren. 2005.
The polysaccharide capsule of Campylobacter jejuni, p. 249–258. In J. M.
Ketley and M. E. Konkel (ed.), Campylobacter: molecular and cellular biol-
ogy. Horizon Bioscience, Norfolk, United Kingdom.
19. Kelly, D. J. 2005. Metabolism, electron transport and bioenergetics of
Campylobacter jejuni: implications for understanding life in the gut and
survival in the environment, p. 275–292. In J. M. Ketley and M. E. Konkel
(ed.), Campylobacter: molecular and cellular biology. Horizon Bioscience,
Norfolk, United Kingdom.
20. Larsen, J. C., C. Szymanski, and P. Guerry. 2004. N-linked protein glyco-
sylation is required for full competence in Campylobacter jejuni 81-176. J.
Bacteriol. 186:6508–6514.
21. Lin, J., M. Akiba, O. Sahin, and Q. Zhang. 2005. CmeR functions as a
transcriptional repressor for the multidrug efflux pump CmeABC in Campy-
lobacter jejuni. Antimicrob. Agents Chemother. 49:1067–1075.
22. Lin, J., C. Cagliero, B. Guo, Y. W. Barton, M. C. Maurel, S. Payot, and Q.
Zhang. 2005. Bile salts modulate expression of the CmeABC multidrug efflux
pump in Campylobacter jejuni. J. Bacteriol. 187:7417–7424.
23. Lin, J., L. O. Michel, and Q. Zhang. 2002. CmeABC functions as a multidrug
efflux system in Campylobacter jejuni. Antimicrob. Agents Chemother. 46:
2124–2131.
24. Lin, J., O. Sahin, L. O. Michel, and Q. Zhang. 2003. Critical role of multi-
VOL. 190, 2008 GENES REGULATED BY CmeR IN CAMPYLOBACTER 1889
drug efflux pump CmeABC in bile resistance and in vivo colonization of
Campylobacter jejuni. Infect. Immun. 71:4250–4259.
25. Lloyd, A. L., B. J. Marshall, and B. J. Mee. 2005. Identifying cloned Heli-
cobacter pylori promoters by primer extension using a FAM-labelled primer
and GeneScan analysis. J. Microbiol. Methods 60:291–298.
26. Luong, T. T., P. M. Dunman, E. Murphy, S. J. Projan, and C. Y. Lee. 2006.
Transcription profiling of the mgrA regulon in Staphylococcus aureus. J.
Bacteriol. 188:1899–1910.
27. Luong, T. T., S. W. Newell, and C. Y. Lee. 2003. Mgr, a novel global regulator
in Staphylococcus aureus. J. Bacteriol. 185:3703–3710.
28. MacKichan, J. K., E. C. Gaynor, C. Chang, S. Cawthraw, D. G. Newell, J. F.
Miller, and S. Falkow. 2004. The Campylobacter jejuni dccRS two-compo-
nent system is required for optimal in vivo colonization but is dispensable for
in vitro growth. Mol. Microbiol. 54:1269–1286.
29. Miller, W. G., A. H. Bates, S. T. Horn, M. T. Brandl, M. R. Wachtel, and
R. E. Mandrell. 2000. Detection on surfaces and in Caco-2 cells of Campy-
lobacter jejuni cells transformed with new gfp, yfp, and cfp marker plasmids.
Appl. Environ. Microbiol. 66:5426–5436.
30. Murphy, C., C. Carroll, and K. N. Jordan. 2006. Environmental survival
mechanisms of the foodborne pathogen Campylobacter jejuni. J. Appl. Mi-
crobiol. 100:623–632.
31. Palyada, K., D. Threadgill, and A. Stintzi. 2004. Iron acquisition and regu-
lation in Campylobacter jejuni. J. Bacteriol. 186:4714–4729.
32. Parkhill, J., B. W. Wren, K. Mungall, J. M. Ketley, C. Churcher, D. Basham,
T. Chillingworth, R. M. Davies, T. Feltwell, S. Holroyd, K. Jagels, A. V.
Karlyshev, S. Moule, M. J. Pallen, C. W. Penn, M. A. Quail, M. A. Rajan-
dream, K. M. Rutherford, A. H. van Vliet, S. Whitehead, and B. G. Barrell.
2000. The genome sequence of the food-borne pathogen Campylobacter
jejuni reveals hypervariable sequences. Nature 403:665–668.
33. Pennella, M. A., and D. P. Giedroc. 2005. Structural determinants of metal
selectivity in prokaryotic metal-responsive transcriptional regulators. Bio-
metals 18:413–428.
34. Petersen, L., T. S. Larsen, D. W. Ussery, S. L. On, and A. Krogh. 2003. RpoD
promoters in Campylobacter jejuni exhibit a strong periodic signal instead of
a 35 box. J. Mol. Biol. 326:1361–1372.
35. Poly, F., T. Read, D. R. Tribble, S. Baqar, M. Lorenzo, and P. Guerry. 2007.
Genome sequence of a clinical isolate of Campylobacter jejuni from Thai-
land. Infect. Immun. 75:3425–3433.
36. Raphael, B. H., S. Pereira, G. A. Flom, Q. Zhang, J. M. Ketley, and M. E.
Konkel. 2005. The Campylobacter jejuni response regulator, CbrR, modu-
lates sodium deoxycholate resistance and chicken colonization. J. Bacteriol.
187:3662–3670.
37. Sellars, M. J., S. J. Hall, and D. J. Kelly. 2002. Growth of Campylobacter
jejuni supported by respiration of fumarate, nitrate, nitrite, trimethylamine-
N-oxide, or dimethyl sulfoxide requires oxygen. J. Bacteriol. 184:4187–4196.
38. Skirrow, M. B., and M. J. Blaser. 2000. Clinical aspects of Campylobacter
infection, p. 69–88. In I. Nachamkin and M. J. Blaser (ed.), Campylobacter,
2nd ed. American Society for Microbiology, Washington, DC.
39. Stintzi, A. 2003. Gene expression profile of Campylobacter jejuni in response
to growth temperature variation. J. Bacteriol. 185:2009–2016.
40. Stintzi, A., D. Marlow, K. Palyada, H. Naikare, R. Panciera, L. Whitworth,
and C. Clarke. 2005. Use of genome-wide expression profiling and mutagen-
esis to study the intestinal lifestyle of Campylobacter jejuni. Infect. Immun.
73:1797–1810.
41. St. Michael, F., C. M. Szymanski, J. Li, K. H. Chan, N. H. Khieu, S.
Larocque, W. W. Wakarchuk, J. R. Brisson, and M. A. Monteiro. 2002. The
structures of the lipooligosaccharide and capsule polysaccharide of Campy-
lobacter jejuni genome sequenced strain NCTC 11168. Eur. J. Biochem.
269:5119–5136.
42. Storey, J. D., and R. Tibshirani. 2003. Statistical significance for genomewide
studies. Proc. Natl. Acad. Sci. USA 100:9440–9445.
43. Truong-Bolduc, Q. C., P. M. Dunman, J. Strahilevitz, S. J. Projan, and D. C.
Hooper. 2005. MgrA is a multiple regulator of two new efflux pumps in
Staphylococcus aureus. J. Bacteriol. 187:2395–2405.
44. Truong-Bolduc, Q. C., and D. C. Hooper. 2007. The transcriptional regula-
tors NorG and MgrA modulate resistance to both quinolones and beta-
lactams in Staphylococcus aureus. J. Bacteriol. 189:2996–3005.
45. van Vliet, A. H. M., K. G. Wooldridge, and J. M. Ketley. 1998. Iron-respon-
sive gene regulation in a Campylobacter jejuni fur mutant. J. Bacteriol. 180:
5291–5298.
46. Wang, Y., and D. E. Taylor. 1990. Chloramphenicol resistance in Campy-
lobacter coli: nucleotide sequence, expression, and cloning vector construc-
tion. Gene 94:23–28.
47. Woodall, C. A., M. A. Jones, P. A. Barrow, J. Hinds, G. L. Marsden, D. J.
Kelly, N. Dorrell, B. W. Wren, and D. J. Maskell. 2005. Campylobacter jejuni
gene expression in the chick cecum: evidence for adaptation to a low-oxygen
environment. Infect. Immun. 73:5278–5285.
48. Wosten, M. M., M. Boeve, M. G. Koot, A. C. van Nuene, and B. A. van der
Zeijst. 1998. Identification of Campylobacter jejuni promoter sequences. J.
Bacteriol. 180:594–599.
49. Wosten, M. M., C. T. Parker, A. van Mourik, M. R. Guilhabert, L. van Dijk,
and J. P. van Putten. 2006. The Campylobacter jejuni PhosS/PhosR operon
represents a non-classical phosphate-sensitive two-component system. Mol.
Microbiol. 62:278–291.
50. Wosten, M. M., J. A. Wagenaar, and J. P. van Putten. 2004. The FlgS/FlgR
two-component signal transduction system regulates the fla regulon in
Campylobacter jejuni. J. Biol. Chem. 279:16214–16222.
51. Yang, Y. H., S. Dudoit, P. Luu, D. M. Lin, V. Peng, J. Ngai, and T. P. Speed.
2002. Normalization for cDNA microarray data: a robust composite method
addressing single and multiple slide systematic variation. Nucleic Acids Res.
30:e15.
52. Yao, R., R. A. Alm, T. J. Trust, and P. Guerry. 1993. Construction of new
Campylobacter cloning vectors and a new mutational cat cassette. Gene
130:127–130.
53. Yao, R., D. H. Burr, and P. Guerry. 1997. CheY-mediated modulation of
Campylobacter jejuni virulence. Mol. Microbiol. 23:1021–1031.
1890 GUO ET AL. J. BACTERIOL.
